FDA breakthrough therapy status to LSD analog…
…an LSD analog, L S D (Lysergide D-Tartrate) was given “breakthrough therapy” designation by the FDA for treating anxiety. …this analog… a tartrate salt form… called MM-120. A single oral administration (100 µg) of this psychelic analog, MM120, maintained a clinically and statistically significant reduction in symptoms compared to placebo at 12 weeks — with…
Recent Comments